Navigation Links
PriceSpective Continues Global Expansion With New San Diego Office
Date:9/8/2009

Dan Ross to Lead Business Development Team

PHILADELPHIA, Sept. 8 /PRNewswire/ -- PriceSpective, a value strategy consultancy that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, is pleased to announce that it has hired Dan Ross to open its new San Diego office.

Ross brings 9 years of experience working with healthcare companies in both investment banking and strategic consulting capacities. His primary role will be to enhance PriceSpective's pricing and reimbursement, forecasting, and business development services. Within the business development offering, PriceSpective now has a team dedicated to assisting clients with licensing valuations, global pricing and market access due diligence, and negotiations associated with partnering products in early stage development.

This combination of enhanced early-stage business development services and PriceSpective's strategic pricing and reimbursement offerings enables the unique capability of providing clients with credible assumptions and model inputs that can drive long-range forecasts and serve as the foundation for licensing discussions. While located in one of the biotech rich areas of the United States, the San Diego office will also support PriceSpective's clients around the globe.

"As we execute our strategy to build our consulting and services capabilities," said CEO Steve Slovick, "Dan and other recent hires will ensure that our clients continue to receive high quality and high value advice. Our growing presence in the pharmaceutical consultancy continues to suggest that PriceSpective is rapidly moving toward the 'Best in Class' position we strive to achieve. This ongoing growth, such as the new San Diego office, will provide us with additional opportunities for expansion as we continue to plan for increased offerings and geographical coverage. I am delighted that someone as talented as Dan has joined our team."

Previously, Ross worked as the Director in charge of the global life sciences licensing, and valuation practice for Simon-Kucher& Partners (SKP). In this role, Ross worked closely with the bio-pharmaceutical and medical device companies to support a number of licensing transactions as an advisor to either the out- or in-licensing party. Prior to serving as a consultant to the health care industry, Ross worked with many of the same clients as an investment banker within Citigroup / Salomon Smith Barney's Health Care / Biotech Investment Banking division.

Ross received his Masters in Business Administration from Stanford University's Graduate School of Business.

About PriceSpective

PriceSpective is a management consulting firm specializing in innovative strategies to identify, capture and communicate value for companies in the biopharmaceutical arena. We are uniquely positioned to deliver expert guidance in integrated global pricing, reimbursement and market access strategy due to our depth of experience and the active engagement of our senior leadership.

Over the last year, PriceSpective has climbed from position #413 on Inc 500's list of 'Fastest Growing Private Companies in America' to # 174. PriceSpective has offices in Los Angeles, San Diego, Philadelphia and London and has a global staff of 49 professionals.


'/>"/>
SOURCE PriceSpective
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Healthcare Continues to Use OnBase in Meaningful Ways
2. RainEarth (RNER) Continues to Expand its Marketing Force in China
3. Cord Blood America Continues International Expansion
4. Bio-Optronics Adds Innovative Electronic Data Capture (EDC) Solution to Clinical Conductor Clinical Trial Management System (CTMS), Continues to Improve Workflow and Productivity
5. Voler Systems Continues Investments and Expands Services
6. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
7. SleepQuest Continues to Fight for Sleep Apnea Education
8. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
9. ACORN CRO Continues Growth in Strong Third Quarter
10. ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results
11. Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):